Cargando…

Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis

To reduce potentially inappropriate medications, the FORTA (Fit fOR The Aged) concept classifies drugs in terms of their suitability for geriatric patients with different labels, namely A (indispensable), B (beneficial), C (questionable), and D (avoid). The aims of our study were to assess the medic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greten, S., Müller-Funogea, J. I., Wegner, F., Höglinger, G. U., Simon, N., Junius-Walker, U., Gerbel, S., Krause, O., Klietz, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2020
Materias:	Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815558/ https://www.ncbi.nlm.nih.gov/pubmed/33263172 http://dx.doi.org/10.1007/s00702-020-02276-x

Ejemplares similares

Disease modification in Parkinsonism: obstacles and ways forward
por: Höllerhage, M., et al.
Publicado: (2022)

Case report: Early-onset Parkinson's disease with initial spastic paraparesis and hyperreflexia caused by compound heterozygous PRKN-gene exon 2 and 4 deletions
por: Jensen, Ida, et al.
Publicado: (2022)

Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study
por: Schulze Westhoff, Martin, et al.
Publicado: (2022)

Patient Safety in a Box: Implementation and Evaluation of the Emergency Box in Geriatric and Parkinson Patients
por: Krey, Lea, et al.
Publicado: (2021)

Epidemiology, clinical presentation, treatment, and outcome of neurosarcoidosis: A mono-centric retrospective study and literature review
por: Sambon, Pauline, et al.
Publicado: (2022)

Patient-Centric Care for Parkinson's Disease: From Hospital to the Community
por: Aye, Yin Minn, et al.
Publicado: (2020)

Altered Neurometabolic Profile in Early Parkinson's Disease: A Study With Short Echo-Time Whole Brain MR Spectroscopic Imaging
por: Klietz, Martin, et al.
Publicado: (2019)

Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study
por: Drexel, S. C., et al.
Publicado: (2019)

Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study
por: Kutschenko, Anna, et al.
Publicado: (2020)

DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
por: Respondek, Gesine, et al.
Publicado: (2021)

Parkinson’s disease therapy: what lies ahead?
por: Wolff, Andreas, et al.
Publicado: (2023)

Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient
por: Huber, Meret, et al.
Publicado: (2020)

Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
por: Krüger, Rejko, et al.
Publicado: (2017)

Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson´s disease
por: Krause, Patricia, et al.
Publicado: (2022)

Knowledge on and use of the FORTA (“Fit fOR The Aged”)-list and the FORTA App by general practitioners in Baden-Württemberg, Germany
por: Meyer, Liesbeth, et al.
Publicado: (2020)

Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy
por: Klietz, Martin, et al.
Publicado: (2021)

Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy
por: Kwasny, Mary J., et al.
Publicado: (2021)

Human-Centric Lighting: Foundational Considerations and a Five-Step Design Process
por: Houser, Kevin W., et al.
Publicado: (2021)

Mindfulness and Psychological Flexibility are Inversely Associated with Caregiver Burden in Parkinson’s Disease
por: Klietz, Martin, et al.
Publicado: (2020)

Correction to: Knowledge on and use of the FORTA (“Fit fOR The Aged”)‑list and the FORTA App by general practitioners in Baden‑Württemberg, Germany
por: Meyer, Liesbeth, et al.
Publicado: (2021)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

The heterogeneity of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2023)

Glucocerebrosidase mutations and Parkinson disease
por: Vieira, Sophia R. L., et al.
Publicado: (2022)

Life style and Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2022)

Deep brain stimulation in Early Onset Parkinson's disease
por: Krause, Patricia, et al.
Publicado: (2022)

Medication optimization according to the Fit fOR The Aged (FORTA) rules improves functional status in patients hospitalized for geriatric rehabilitation
por: Pazan, Farhad, et al.
Publicado: (2023)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

GBA-associated PD: chances and obstacles for targeted treatment strategies
por: Höglinger, Günter, et al.
Publicado: (2022)

Treatment of Parkinson’s disease in the advanced stage
por: Ossig, C., et al.
Publicado: (2013)

Small intestine dysfunction in Parkinson’s disease
por: Dutkiewicz, Justyna, et al.
Publicado: (2015)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Sleep and non-motor symptoms in Parkinson’s disease
por: Maass, Antonia, et al.
Publicado: (2013)

Parkinson’s disease between internal medicine and neurology
por: Csoti, Ilona, et al.
Publicado: (2015)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021)

Genetic testing for Parkinson’s disease in clinical practice
por: Gasser, Thomas
Publicado: (2023)

The use of wearables for the diagnosis and treatment of Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2023)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer’s disease and other neuropsychiatric disorders
por: North, Hilary, et al.
Publicado: (2023)

Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein
por: Höllerhage, Matthias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ctmraig5b8ehb15bsstg3ef13